日本語
TOP page
Published papers
Academic conference presentation
(Last updated : 2024-11-14 10:49:12)
Yoshino Maki
Department
School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Urology
Position
Assistant Professor
■
Published papers
1.
Original article
Survival impact of glucocorticoid administration for adverse events during immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma. 2024/07
2.
Original article
Effects of remote ischemic preconditioning on renal protection in patients undergoing robot-assisted laparoscopic partial nephrectomy. 2023/10
3.
Original article
New longitudinal component of the RENAL nephrometry score for predicting the operative complexity in transperitoneal robot-assisted partial nephrectomy. 2022/06
4.
Original article
Albumin-to-alkaline phosphatase ratio as a novel prognostic marker of nivolumab monotherapy for previously treated metastatic renal cell carcinoma. 2021/09
■
Academic conference presentation
1.
Impact of corticosteroid administration on treatment effectiveness in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitor-based combination therapy. 2024/05/03
2.
BRCA mutation-positive prostate cancer at our hospital initial experience with olaparib in BRCA mutation-positive prostate cancer. 2024/04/26
3.
Impact of steroids for immune-related adverse events in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitor combination therapy. 2024/04/26
4.
Utility of whole-body MRI (DWIBS) in treatment decision-making for M0CRPC: A case series study. 2024/04/26
5.
Effect of remote ischemic preconditioning on renal protection in patients undergoing robot-assisted laparoscopic partial nephrectomy. 2023/04/21
6.
Potential survival benefit of deferred nephrectomy in patients treated with nivolumab plus ipilimumab for metastatic renal cell carcinoma. 2022/05/13
7.
Predictive factors related to the number of TUL for kidney stones in our hospital. 2020/12/22
8.
Treatment outcome of abiraterone plus prednisone in patients with high-risk metastatic castration-sensitive prostate cancer in Saiseikai Kawaguchi hospital. 2020/12/22
9.
Investigation of introduction of early docetaxel for mHRCP in our hospital. 2018/10/21
10.
Utility of whole body MRI for detection and treatment of metastases of prostate cancer. 2018/10/21
Display 5 items
Display all(10)